Group penalized logistic regression differentiates between benign and malignant ovarian tumors

被引:0
|
作者
Hu, Xuemei [1 ,2 ]
Xie, Ying [3 ]
Yang, Yanlin [4 ]
Jiang, Huifeng [5 ]
机构
[1] Chongqing Technol & Business Univ, Sch Math & Stat, Chongqing 400067, Peoples R China
[2] Chongqing Technol & Business Univ, Chongqing Key Lab Social Econ & Appl Stat, Chongqing 400067, Peoples R China
[3] Chongqing Vocat Coll Sci & Technol, Gen Natl Def Educ Coll, Chongqing 400037, Peoples R China
[4] Chongqing Univ, Sch Econ & Business Adm, Chongqing 400044, Peoples R China
[5] Chongqing Technol & Business Univ, Res Ctr Econ Upper Reaches Yangtse River, Chongqing 400067, Peoples R China
关键词
Ovarian cancer; GCD algorithm; GLASSO/GSCAD/GMCP penalty; Machine learning methods; Deep learning methods; VARIABLE SELECTION; CANCER; CA125; HE-4; ROMA;
D O I
10.1007/s00500-023-09231-4
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Ovarian cancer is one of the most common types of cancer in women. Correct differentiation between benign and malignant ovarian tumors is of immense importance in medical fields. In this paper, we introduce group penalized logistic regressions to enhance diagnosis accuracy. Firstly, we divide 349 ovarian cancer patients into two sets: one for learning model parameters, and the other for assessing prediction performance, and select 46 variables from 49 traits as the predictor vector to construct GLASSO/GSCAD/GMCP penalized logistic regressions with 11 groups. Secondly, we develop group coordinate descent (GCD) algorithm and its specific pseudo code to simultaneously complete group selection and group estimation, introduce the tenfold cross validation (CV) procedure to select the relatively optimal tuning parameter, and apply the testing set and Youden index to obtain class probability estimator and class index information. Finally, we compute the accuracy, precision, specificity, sensitivity, F1-score and the area under ROC curve (AUC) to assess the prediction performance to the proposed group penalized methods, and found that GLASSO/GSCAD/GMCP penalized logistic regressions outperform three machine learning methods (ANN, artificial neural network; SVM, support vector machine; XGBoost, eXtreme gradient boosting) and three deep learning methods (CNN, convolutional neural network; DNN, deep neural network; RNN, recurrent neural network) in terms of accuracy, F1-score and AUC.
引用
收藏
页码:18565 / 18584
页数:20
相关论文
共 50 条
  • [41] Differences in p16 gene methylation and expression in benign and malignant ovarian tumors
    McCluskey, LL
    Chen, C
    Delgadillo, E
    Felix, JC
    Muderspach, LI
    Dubeau, L
    GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 87 - 92
  • [42] p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
    Cabral, Vinicius Duarte
    Cerski, Marcelle Reesink
    Brito, Ivana Trindade Sa
    Kliemann, Lucia Maria
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [43] Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses
    Jose Hidalgo, Juan
    Llueca, Antoni
    Zolfaroli, Irene
    Veiga, Nadia
    Ortiz, Ester
    Luis Alcazar, Juan
    MEDICAL ULTRASONOGRAPHY, 2021, 23 (02) : 168 - 175
  • [44] Contrast-enhanced ultrasound for differential diagnosis of malignant and benign ovarian tumors: systematic review and meta-analysis
    Ma, X.
    Zhao, Y.
    Zhang, B.
    Ling, W.
    Zhuo, H.
    Jia, H.
    Li, P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 46 (03) : 277 - 283
  • [45] Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry
    Zhang, Tao
    Wu, Xiaoyan
    Yin, Mingzhu
    Fan, Lijun
    Zhang, Haiyu
    Zhao, Falin
    Zhang, Wang
    Ke, Chaofu
    Zhang, Guangming
    Hou, Yan
    Zhou, Xiaohua
    Lou, Ge
    Li, Kang
    CLINICA CHIMICA ACTA, 2012, 413 (9-10) : 861 - 868
  • [46] Validity of ultrasound with color Doppler to differentiate between benign and malignant ovarian tumours
    Mahale, Nina
    Kumar, Neeti
    Mahale, Ajit
    Ullal, Sonali
    Fernandes, Merwyn
    Prabhu, Sonali
    OBSTETRICS & GYNECOLOGY SCIENCE, 2024, 67 (02) : 227 - 234
  • [47] Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals
    Zvarik, M.
    Martinicky, D.
    Hunakova, L.
    Sikurova, L.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2015, 153 : 191 - 197
  • [48] Systematic review and meta-analysis of imaging differential diagnosis of benign and malignant ovarian tumors
    Wang, Wen-Huan
    Zheng, Chang-Bao
    Gao, Jin-Niao
    Ren, Shang-Shang
    Nie, Guo-Yan
    Li, Zhi-Qun
    GLAND SURGERY, 2022, 11 (02) : 330 - 340
  • [49] Ultrasound image analysis using deep neural networks for discriminating between benign and malignant ovarian tumors: comparison with expert subjective assessment
    Christiansen, F.
    Epstein, E. L.
    Smedberg, E.
    Akerlund, M.
    Smith, K.
    Epstein, E.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 57 (01) : 155 - 163
  • [50] Decision-Level Fusion Classification of Ovarian CT Benign and Malignant Tumors Based on Radiomics and Deep Learning of Dual Views
    Rong, Qi
    Wu, Wenna
    Lu, Zhentai
    Liao, Shengwu
    IEEE ACCESS, 2024, 12 : 102381 - 102395